Ameritas Investment Partners, Inc. Pfizer Inc Transaction History

Ameritas Investment Partners, Inc.

$2.98 Billion
Q3 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 61,439 shares of PFE stock, worth $1.64 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

61,439

Previous 64,648 4.96%

Holding current value

$1.64 Million

Previous $1.81 Million 1.66%

% of portfolio

0.06%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $88,889 - $100,730	-3,209 Reduced 4.96%	61,439 $1.78 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $34,909 - $40,907	-1,382 Reduced 2.09%	64,648 $1.81 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $41,631 - $47,805	-1,608 Reduced 2.38%	66,030 $1.83 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $72,406 - $94,047	-2,771 Reduced 3.94%	67,638 $1.95 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $58,211 - $68,043	-1,814 Reduced 2.51%	70,409 $2.34 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $31,496 - $36,440	-872 Reduced 1.19%	72,223 $2.65 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $13,668 - $17,794	347 Added 0.48%	73,095 $2.98 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $41,875 - $54,663	-1,003 Reduced 1.36%	72,748 $3.73 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $30,500 - $37,233	-697 Reduced 0.94%	73,751 $3.23 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $108,135 - $128,215	-2,324 Reduced 3.03%	74,448 $3.9 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $84,546 - $104,763	-1,848 Reduced 2.35%	76,772 $3.97 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $171,395 - $254,065	-4,148 Reduced 5.01%	78,620 $4.64 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $195,504 - $251,142	4,981 Added 6.4%	82,768 $3.56 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $25,639 - $29,045	-714 Reduced 0.91%	77,787 $3.05 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $137,007 - $154,517	-4,091 Reduced 4.95%	78,501 $2.84 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $194,126 - $246,848	-5,800 Reduced 6.56%	82,592 $3.04 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $128,651 - $150,937	-4,052 Reduced 4.38%	88,392 $3.24 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $52,167 - $63,287	-1,732 Reduced 1.84%	92,444 $3.02 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $55,898 - $79,866	-2,068 Reduced 2.15%	94,176 $3.07 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $34,697 - $39,377	-1,054 Reduced 1.08%	96,244 $3.77 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $94,091 - $122,008	-2,896 Reduced 2.89%	97,298 $3.5 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $51,291 - $57,588	-1,387 Reduced 1.37%	100,194 $4.34 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $151,762 - $166,736	-4,047 Reduced 3.83%	101,581 $4.31 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $154,457 - $176,097	-4,015 Reduced 3.66%	105,628 $4.61 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $87,140 - $105,695	-2,528 Reduced 2.25%	109,643 $4.83 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $455,948 - $486,086	-13,825 Reduced 10.97%	112,171 $4.07 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $185,397 - $215,086	-5,810 Reduced 4.41%	125,996 $4.47 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $194,205 - $206,058	-5,839 Reduced 4.24%	131,806 $4.7 Million
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $15,500 - $17,075	500 Added 0.36%	137,645 $4.67 Million
Q2 2017 Aug 15, 2017	BUY	N/A	137,145	137,145 $4.61 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Pfizer Inc Transaction History